Alnylam Pharmaceuticals
ALNY
#534
Rank
A$64.81 B
Marketcap
A$490.61
Share price
0.88%
Change (1 day)
9.79%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company